Hoxworth Blood Center celebrates 9th annual golf outing and fundraiser event to raise money for a new blood mobile

Hoxworth Blood Center, University of Cincinnati, held its 9th annual golf outing and fundraiser event on Thursday, September 14, 2023, at Losantiville Country Club to raise funds for a new bloodmobile to continue their lifesaving mission. The event was supported by 25 sponsors, 105 golfers, various Hoxworth staff & volunteers, making it a memorable day of celebrating saving lives close to home. 

Hoxworth extends its deepest appreciation to the 2023 sponsors who made this event a reality:

Several organizations generously donated prizes, gift baskets, gift certificates, and other items for the golf outing raffle and online silent auction. Participants were also gifted with a Hoxworth swag bag and treated to meals for the day provided by local Cincinnati Favorite restaurants; Busken Bakery for breakfast, Skyline Chili for lunch and Montgomery Inn for dinner.

 Hoxworth’s annual fundraising event makes a significant impact towards its lifesaving mission and the community at large. We are so grateful to everyone who made it possible: golf participants, sponsors, volunteers, and those who supported from afar, your contributions are invaluable. 

View highlights from the day: click here!

About Hoxworth:
Hoxworth Blood Center, University of Cincinnati, was founded in 1938, and serves more than 30 hospitals in 18 counties in Southwestern Ohio, Northern Kentucky and Southeastern Indiana. Annually, Hoxworth collects more than 100,000 units of blood from local donors to help save the lives of patients in area hospitals. Hoxworth Blood Center: Saving Lives Close to Home. 

Related Stories

2

Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy

March 16, 2026

Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.